| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.20B | 17.05B | 16.83B | 17.11B | 14.48B | 13.82B |
| Gross Profit | 8.40B | 9.31B | 9.45B | 9.62B | 8.11B | 7.65B |
| EBITDA | 8.96B | 8.67B | 8.89B | 9.07B | 7.61B | 7.65B |
| Net Income | 4.62B | 4.45B | 5.63B | 5.12B | 4.90B | 3.54B |
Balance Sheet | ||||||
| Total Assets | 57.65B | 57.07B | 52.67B | 50.66B | 48.54B | 44.80B |
| Cash, Cash Equivalents and Short-Term Investments | 226.00M | 389.00M | 475.00M | 328.00M | 838.00M | 569.00M |
| Total Debt | 21.46B | 21.37B | 18.89B | 15.89B | 12.91B | 13.32B |
| Total Liabilities | 36.38B | 36.02B | 32.55B | 29.28B | 25.79B | 25.15B |
| Stockholders Equity | 21.27B | 21.05B | 20.12B | 21.38B | 22.74B | 19.65B |
Cash Flow | ||||||
| Free Cash Flow | 3.44B | 3.15B | 3.78B | 3.92B | 4.08B | 3.30B |
| Operating Cash Flow | 6.82B | 6.70B | 6.96B | 6.67B | 6.97B | 6.17B |
| Investing Cash Flow | -3.44B | -3.61B | -3.47B | -2.51B | -2.87B | -2.95B |
| Financing Cash Flow | -3.85B | -3.62B | -3.41B | -4.67B | -3.86B | -2.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | C$11.22B | 21.62 | 19.66% | 1.58% | 1.32% | 24.27% | |
77 Outperform | C$85.73B | 18.91 | 22.24% | 2.62% | 0.23% | -13.22% | |
74 Outperform | C$90.93B | 21.93 | 9.32% | 0.82% | 4.02% | 21.39% | |
69 Neutral | C$612.81M | 13.30 | 8.84% | 5.09% | 3.71% | -12.70% | |
67 Neutral | C$12.77B | 28.82 | 11.98% | 1.75% | -0.25% | -28.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | C$855.81M | 20.37 | 8.55% | ― | -2.83% | 179.03% |